Audited Results of Aarti Drugs Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	2,173.65	2,266.91	2,497.97	2,251.17	1,914.89
Manufacturing Expenses	318.99	292	286.45	258.43	203.41
Personnel Expenses	85.25	80.98	74.99	69.32	69.29
Selling Expenses	0.69	1.08	0.35	0.35	0.27
Administrative Expenses	74.12	62.65	77.91	75.58	59.82
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,911	2,000.78	2,215.57	1,932.99	1,513.62
Operating Profit	262.65	266.13	282.40	318.18	401.27
Other Recurring Income	13.57	4.18	2.23	4.77	6.42
Adjusted PBDIT	276.22	270.31	284.64	322.96	407.69
Financial Expenses	29.68	30.16	32.53	20.07	22.61
Depreciation	47.79	47.67	47.29	47.39	47.60
Other Write offs	0	0	0	0	0
Adjusted PBT	198.75	192.48	204.81	255.50	337.49
Tax Charges	41.44	50.60	52	60.50	80
Adjusted PAT	157.31	141.88	152.81	195	257.49
Non Recurring Items	0	0	0	0	0.22
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	157.31	141.88	152.81	195	257.71
Equity Dividend	9.13	9.19	9.26	9.26	23.30
Preference Dividend	0	0	0	0	0
Retained Earnings	1,200.50	1,079.82	962.41	890	799.93

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article